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Many of the spectrophotometric techniques used to determine the properties of 
intracellular human hemoglobin cannot be utilized due to the turbidity of erythrocyte 
suspensions. An Integrating Cavity Absorption Meter, or ICAM, allows for absorption 
measurements of strongly scattering samples in the visible-light region of the spectrum.  
The spectrum of oxygenated hemoglobin within erythrocytes is significantly different 
from the absorption spectrum of oxygenated hemoglobin in solution.  Studies of the 
oxygen binding to hemoglobin in erythrocytes allowed the four sequential binding 
constants (Adair constants) to be determined and compared with those of hemoglobin in 
solution.  The Adair constants for hemoglobin in solution were found to be markedly 
different from those of hemoglobin in the erythrocyte.
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Chapter 1 Introduction to Hemoglobin 
1.1 The Structure of Hemoglobin 
In 1959, Perutz elucidated the structure of horse hemoglobin using x-ray crystallography 
techniques, and in 1963 revealed the structure of human hemoglobin.1,2  Adult 
hemoglobin consists of two α-globins and two β-globins which each contain a heme 
group.  The heme is a porphyrin ring with an iron atom at its center.  The tertiary 
structure refers to a polypeptide backboard with multiple structural components, while 
the quaternary structure refers to the interaction of multiple polypeptides within the same 
structure.  There are two conformations of the heme globins; the T-state and the R-state.  
In the R-state, its oxygenated form, the heme lies in an isolated packet where it is tightly 
wedged between the 16 side chains of the globin.  This allows no movement of the iron 
from the plane of the porphyrin ring.  The iron forms 6-coordinates: four bonds to the 
porphyrin ring, one bond to histidine, and the sixth to the oxygen.  In the deoxygenated 
T-state, the iron is in its 5 coordinated form, and the iron becomes displaced from the 
porphyrin plane by 0.4 Å.3  The T-state is obstructed by the distal valine on the ligation 
side, and this obstruction cannot be cleared without a change in the polypeptide structure.  
Within these two different conformations, the globins determine the relationship of the 
iron within the porphyrin ring.  As pointed out by Perutz and others, the dominant 
structural change between all four globins can be described as the α1β1 and α2β2 dimers 
remaining rigid while the contacts between α1β2, α2β1, α1α2, and β1β2 move relative to each 
other.2,4  During deoxygenation, the α1α2, α1β1, and α2β2 heme distances remain stationary 
while the α1β1 and α2β2 act as hinges for the β1β2 heme distance increases 5Å (fig. 1.1 and 
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1.2).5  The increase of the hemoglobin during the oxy-to-deoxy transition has been 
termed a “molecular lung in reverse.”3 
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Figure 1.1: Molecular Lung in Reverse: Oxyhemoglobin 
The α-globins are shown in transparent black, and the β-globins are shown in transparent 
blue.  The heme groups are represented in solid black. 
 
 
Structure Distance 
Feβ1 - Feβ2 34.6 Å 
Feα1 - Feβ2 25.5 Å 
Feα1 - Feα2 34.7 Å 
 
Table 1.1: Heme Iron Distances in Oxyhemoglobin 
The heme iron distances remain consistent during the oxy-deoxy transition of 
hemoglobin, except for the Feβ1 - Feβ2 heme distances, which increase 5 Å. 
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Figure 1.2: Molecular Lung in Reverse: Deoxyhemoglobin 
The α-globins are shown in transparent black, and the β-globins are shown in transparent 
blue.  The heme groups are represented in solid black. 
 
 
Structure Distance 
Feβ1 - Feβ2 39.5 Å 
Feα1 - Feβ2 24.3 Å 
Feα1 - Feα2 34.2 Å 
 
Table 1.2: Heme Iron Distances in Deoxyhemoglobin 
The heme iron distances remain consistent during the oxy-deoxy transition of 
hemoglobin, except for the Feβ1 - Feβ2 heme distances, which increase 5 Å.  
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1.2 The History of Hemoglobin Research 
Hemoglobin has been of great interest to the scientific community for the past two 
hundred years. In 1825, Engelhart showed that the iron-to-protein ratio in hemoglobin 
was similar across multiple species.6  In 1878, Bert gave the first crude measurements of 
oxygen binding affinity.7 In 1890, Hüfner crystallized both oxyhemoglobin and 
deoxyhemoglobin.  When the deoxyhemoglobin crystal was exposed to oxygen, the 
crystals shattered, indicating a change in the size and conformation of the hemoglobin.  
Gasometric measurements in 1909 and 1922 were used by Barcroft, Haldane, and 
coworkers to study the thermodynamics of hemoglobin.8,9  In 1924, Adair’s dialysis 
experiments determined the molecular weight of hemoglobin.10  At the time, the 
molecular weight of each globin was known to be 16,000, but the multiple of the globins 
was unknown.  Adair determined the four globins of hemoglobin by comparing the 
molecular weight of each globin to the molecular weight of hemoglobin and the percent 
iron in the protein.  In 1924, the refined gasometric measurements by Adair and others 
were the first attempts to determine sequential binding constants, the Adair constants, to 
be determined for mammalian hemoglobins.11,12  With Adair’s work, the tetrameric 
nature of hemoglobin was discovered, the molecular mass of the tetramer protein found, 
and the initial groundwork for the binding constants laid. 
(1) ?̅? =
1
4
∗
𝐾𝐼[𝑥]+2𝐾1𝐾2[𝑥]
2+3𝐾1𝐾2𝐾3[𝑥]
3+4𝐾1𝐾2𝐾3𝐾4[𝑥]
4
1+𝐾1[𝑥]+𝐾1𝐾2[𝑥]2+𝐾1𝐾2𝐾3[𝑥]3+𝐾1𝐾2𝐾3𝐾4[𝑥]4
  
Where ?̅?represents the oxygen saturation of the hemoglobin and x represents the oxygen 
concentration. 
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Gasometric techniques can be described using a Van Slyke apparatus.13 The Van 
Slyke apparatus uses a roundbottom flask filled with a solution of deoxygenated 
hemoglobin. A measured amount of air with oxygen is introduced to the flask, and given 
time to equilibrate.  A small drop in the pressure indicated the binding of oxygen to 
hemoglobin.  The gasometric measurements take considerable amounts of time, and are 
prone to high percent errors for the Adair constants.  
Following the development of spectrophotometers, the ground work for 
tonometric methods, thin-layers and automated methods were developed in which the 
oxygen concentration was determined by dilution factors, calibrated flow methods, or by 
oxygen electrodes.14-16 These techniques provided more precise data points, allowed 
multiple measurements per sample, and required much less protein, resulting in the 
replacement of the gasometric methods.  Two of the methods related to our work are 
included below. 
1.3 Imai’s Hemoglobin Research 
Imai, often considered Adair’s protégé, worked extensively on the ligand-binding 
properties of hemoglobin.  In the 1970s and 1980s, Imai et. al. developed a method to 
study the functional properties of abnormal hemoglobin, and later improved this method 
to determine the oxygen-hemoglobin equilibrium curves.17  The Imai method uses the 
absorbance changes of hemoglobin at a single wavelength to determine the oxygen 
saturation, and using an oxygen electrode to determine the oxygen concentration.  A 
solution of oxyhemoglobin is placed into a cell with magnetic stirring.  The cell is placed 
in the path of a double-beam spectrophotometer with the path length ranging from 5 to 25 
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mm.  The temperature is controlled by water circulating around the cell.   A small 
thermistor is placed within the cell to measure the temperature of the sample.  The gas 
phase above the liquid is filled and continuously replaced with argon or nitrogen, and the 
dissolved oxygen is removed from the solution.  The fractional saturation of the 
hemoglobin is calculated via:  
(2) ?̅? = [𝐴𝑏𝑠(𝑥) − 𝐴𝑏𝑠(0)]/[𝐴𝑏𝑠(∞) − 𝐴𝑏𝑠(0)]  
Where ?̅? represents the fractional saturation of hemoglobin by oxygen, Abs(x) represents 
the absorbance at a particular wavelength at a given oxygen concentration, Abs(0) 
represents the absorbance at a particular wavelength where the hemoglobin is fully 
deoxygenated, and Abs(∞) represents the absorbance at a particular wavelength where the 
hemoglobin is fully oxygenated.  Imai’s body of work resulted in a number of studies 
reporting free energy changes for the successive steps of oxygenation for hemoglobin 
underneath a variety of conditions.18 
1.4 Parkhurst’s, Larsen’s, and Meuser’s Hemoglobin Research 
Parkhurst et. al. worked to refine Imai’s method by including an enzymatic 
system as well as a new method for oxygen concentration detection.  This would ensure 
homogenous deoxygenation throughout the sample, eliminating the lag time from the 
gas-liquid equilibration from previous techniques.  Parkhurst’s initial aim was to develop 
an instrument that would allow rapid and continuous determinations of both fractional 
saturation and oxygen depletion by spectrophotometry.19  Two enzyme systems were 
used: 1) glucose oxidase with beta-D-glucose in the presence of catalase, or 2) 
protocatechuate-3,4-dioxygenase in the presence of protocatechuic acid.20,21  The 
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hemoglobin sample was loaded into a stopped-flow cuvette with two syringes, which 
were both filled with oxymyoglobin, bovine serum alblumin and dithiothreitol.  When 
glucose oxidase was used to deoxygenate the sample, the first syringe also contained 
catalase and glucose, while second syringe contained glucose oxidase.  When 
protocatechuate-3,4-dioxygenase was used to deoxygenate the sample, the first syringe 
contained protocatechuic acid and the second syringe contained protocatechuqte-3,4-
dioxygenase.  In their initial set-up, the oxygen activity was detected using myoglobin, 
and the spectrophotometer oscillated between reading the absorbance at 585.9 nm, the 
isosbestic point for oxyhemoglobin and deoxyhemoglobin, and the absorbance at 590.6 
nm, the isosbestic point for oxymyoglobin and deoxymyoglobin.   375 data pairs were 
collected over the 25-minute duration of the hemoglobin deoxygenation, then continued 
for an additional 40 minutes until the deoxygenation had reached completion and to 
assure that the hemoglobin has reached a stable endpoint.   During this work, Parkhurst 
et. al. showed that there was a dependence of apparent fractional saturation on 
wavelength, that is, fractional saturation is not exactly proportional to the absorbance 
change.  All of the spectrophotometric studies before Parkhurst et. al. assumed that an 
absorbance change at a single wavelength can determine the four binding Adair 
constants.  This assumption was challenged by Rifkind and Lumry, and Nasuda-
Kouyama, but not widely accepted.22,23  Parkhurst et. al focused on using multiple 
wavelengths in global fitting to determine the true Adair constants of hemoglobin binding 
to oxygen. 
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Chapter 2 ICAM Design & Calibration 
2.1 Introduction 
In previous spectrophotometric studies of hemoglobin equilibria, the protein needed 
to be in solution, and not inside of the cell.  This was due to the turbidity of erythrocyte 
suspensions.24  Scattering effects have always been a systematic problem in absorption 
measurements.25  There have been various attempts to correct for the scattering.  An 
example of one of these attempts is the Integrating Cavity Absorption Meter, or ICAM. 
ICAMs and their derivatives use spectrophotometers that utilize multiple passes of 
light within the ICAM to increase the measured absorbance of a sample having a low 
concentration of absorbing particles.26  The ICAM itself is a sphere with an entrance and 
exit window, with either the inner or outer diameter of the sphere coated with a highly 
diffuse reflecting white material.  The walls reflect the light in a Lambertian manner until 
photons are either absorbed by the sample, or leaves through either the entrance or exit 
windows.27  ICAMs have been used to study pollution detection or sea particles where 
the samples involved low extinction coefficients.28,29   
Initial work on an ICAM began in 1953 when Walsh proposed that if light is 
introduced through a small entrance window, and the surface of the sphere was 
Lambertian reflective, then any point of reflectance in the ICAM will illuminate all other 
surfaces of the wall equally.30  In 1970, Elterman continued the work by devising an 
integrating cavity and deriving the absorbance coefficients based upon the measured 
absorbances.31  The derivations were based upon the energy of light at all points of the 
walls of the ICAM being equal.  In 1992, Fry continued his work and continued to correct 
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Elterman’s derivations.32,33  The derivations use an average pathlength in the ICAM, 
derived from using the photon energy of light being equal at any one point of the ICAM.   
Parkhurst derived the correct equations for both spherical and cubic ICAM to obtain 
absorbance coefficients from measured absorbance of the ICAM by considering the 
precise distribution of path lengths.  Instead of considering the ICAM with average 
energy, Parkhurst integrated over the probabilities of all pathlengths within the ICAM.    
Using these unpublished results, Parkhurst found that the measured absorbance from an 
ICAM would follow an exponential complement with respect to absorbance per cm in the 
ICAM. The ICAM shape does matters, and the ICAM calculations could not follow a 
linear relationship.   
Two designs of the ICAM were developed.  The equations of the first design, 
denoted ICAM-milk, have been solved by Parkhurst.  In ICAM-milk the sample is in 
solution and does not scatter.34   The ICAM-milk will be used for non-light scattering 
samples to allow detection of low absorbance samples (fig. 2.1 and 2.2) .  The second 
design, named ICAM+milk, cancels the Mie scattering of the erythrocytes by 
overwhelming it.  By adding 1% by volume of 1% fat milk to the ICAM, the caseins and 
the fat globules both scatter the light more than the erythrocytes (fig. 2.3).  The second 
design will focus on placing samples that scatter light in the ICAM+Milk.  The final 
design of the ICAM is shown on figure 2.4, and details of the apparatus can be found in 
appendix A.   Our initial task was to calibrate both ICAMs by comparing the measured 
absorbance from the ICAM to a scaled absorbance from the HPDA 8452 
spectrophotometer of a sample that has no light scattering properties.   Horse heart 
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metmyoglobin, the oxidized form of the myoglobin, was decided to be the sample for 
calibration.  Metmyoglobin was chosen as the standard sample, as it absorbs across the 
visible spectrum, has 4 different peaks to ensure precision on the wavelength basis, and 
does not dissociate nor change its spectrum at a fixed pH.35   
2.2 Materials and Methods 
The initial ICAM design uses a 250 mL roundbottom flask with a sidearm, coated on 
the outside with a thick, even layer of white paint.  A bright pen-light was inserted onto 
the open neck of the roundbottom flask in complete darkness to ensure nearly all light 
was contained except for escape through the two windows.  The walls were diffusely 
reflecting and the light from the walls was isotropic Lambertian scattered. Two windows, 
without any paint, were directly across from one another.  These two windows initially 
allowed the incident light to pass through the roundbottom flask.  In the center top hole, a 
rubber stopper was crafted.  In the center of the rubber stopper a cork borer (a shaft with 
a handle), which was surrounded by rubber on the top and by white waterproof paint on 
the bottom (fig. 2.1).  At the bottom of the shaft a deflector was attached: a thin sheet of 
aluminum painted white, then lightly brushed with sandpaper. When the rubber stopper is 
placed into the top of the roundbottom flask, the rubber stopper with the cork borer 
attached deflects the incident light beam and causes the incident light to reflect onto the 
walls of the ICAM.  When the rubber stopper was put into place, the initial reflection 
back through the entrance was eliminated.  Effectively, an incident photon enters the 
ICAM through the entrance window, becomes scattered by the baffle, and reflects 
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multiple times in the ICAM until it leaves through the exit window, or it is absorbed 
within the ICAM by a sample.  The light leaving the exit window is completely diffuse.   
The final design of the ICAM encompassed a stable temperature control, 
measurement of the temperature of the solution inside of the ICAM, and measurement of 
the oxygen concentration (fig 2.4). A stable temperature was maintained by pumping 
water from a water bath through tygon tubing surrounding the ICAM. The tygon tubing 
was wrapped around the ICAM 15 times.  A hole was made in the rubber stopper and a 
thermistor slid into place.  Refer to figure 2.4 for the placement of these objects.  The 
thermistor was connected to a voltmeter, and a calibration curve of voltage versus 
temperature from 15ºC to 40ºC was established.  The temperature was held at room 
temperature for an hour within ±0.1 degrees.  The sidearm contained an YSI 5300 oxygen 
electrode.36  When placed into the sidearm, an airtight seal was made with silicone 
cement.  The digital signal of the oxygen electrode was converted to analog using a 
Sparkfun Redboard microprocessor, and relayed to a computer through a mini-usb port.   
After several experiments, it was determined that a special apparatus holder 
needed to be designed (appendix A). Our aims for the kinematic design were 1) to allow 
an air-powered stir plate to be introduced underneath the ICAM roundbottom flask, 2) 
allow adjustment of the ICAM for translation and rotation, and 3) to maintain the 
reproducible placement during removal and replacement of the ICAM.37 
During our experimentation, two different set-ups of the ICAM instrument were 
used.   Both utilized a baffle angled such that no incident light would pass through the 
13 
 
ICAM without reflecting off the walls of the ICAM.  This setup was called “ICAM-
milk.”  A second set-up of the ICAM was introduced, which included adding milk before 
the zeroing and baselining processes (fig. 2.3).  The 1% fat milk at 1% by volume within 
the ICAM contains fat globules, roughly 3 µm in diameter at an average separation of 50 
µm.38,39   The fat globules strongly scatter light.40  By introducing 1% (v/v) of 1% fat 
milk, which effectively scatters the light within the ICAM, the average photon would 
have a longer path length in the absence of absorption before exiting the ICAM.  This 
setup was called “ICAM+milk.” 
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Figure 2.1: Model of the ICAM Design 
A represents the entrance window for the incidence light, and B represents the exit 
window for the diffuse light.  In between lies a white baffle secured using a white cork 
bore within a white rubber stopper.  The sidearm was secured with a rubber stopper also 
painted white. 
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Figure 2.2: Model of the Light within the ICAM-Milk 
As the collimated light from the incidence beam travels through the entrance window A, 
the beam is Lambertian scattered by the baffle.  After Lambertian reflection from the 
walls through multiple passes, the scattered light leaves through the windows.     
16 
 
 
 
 
Figure 2.3: Model of the Light within the ICAM+Milk 
As the collimated light from the incidence beam travels through the entrance window A, 
the beam is Lambertian scattered by the baffle and the milk particles.  The light beam can 
be reflected multiple times by the milk before being reflected by a wall.  After 
Lambertian reflection from the walls through multiple passes, the scattered light leaves 
through the windows. 
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Figure 2.4: Model of the ICAM+Milk during the Deoxygenation of Erythrocytes 
A represents the entrance window. B represents the exit window.  C represents the stir 
bar, and D represents the baffle.  E represents the overflow syringe, and F represents the 
enzyme syringe with an open-close valve.  G represents the oxygen electrode.  H 
represents the thermistor.  
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Calibration curves were constructed to test the relationship between the measured 
absorbance of metmyoglobin in solution in the ICAM versus the absorbance per 
centimeter of metmyoglobin in the HPDA 8452.  Metmyoglobin (Mb+), oxidized 
myoglobin, was chosen as the correcting sample, as it absorbs across the visible 
spectrum, and has 4 different absorption peaks at 500 nm, 542 nm, 575m, and 632 nm to 
ensure precision on the wavelength basis.35   
A solution of metmyoglobin was prepared by adding 0.010 grams of potassium 
ferricyanide to 50 mL 50mM phosphate buffer, pH 8.0, with 1.2 grams of horse heart 
myoglobin.  The ferricyanide separated from the Mb+ with a G-25 Sephedex medium 
column.  The column ran for 20 minutes and the metmyoglobin was collected, and well 
separated from the yellow ferricyanide. The concentration taken with the HPDA 8452 
spectrophotometer, after a 1:20 dilution, using the molar extinction coefficient of 9.5*103 
M-1 * cm-1 at 500 nm.41 Using the HPDA 8452 spectrophotometer, a standard 
metmyoglobin spectrum from 500 nm-750nm was taken.  Spectra of increasing 
concentrations of metmyoglobin were taken in the ICAM.  A series of measured 
absorbance spectra in the ICAM+milk and the ICAM-milk were recorded and compared 
compared at each wavelength to the standard scaled absorbances from the standardized 
metmyoglobin spectra from the HPDA 8452.  This plot was fitted well using an 
exponential complement function with an automated Monte-Carlo fitting program within 
Graphpad:42 
(3) 𝑓(𝑥) = 𝐴 ∗ (1 − 𝑒−𝐵∗𝑥) 
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where B represents the exponential decay parameter.  This function serves as a transfer 
function, allowing the measured absorbance of the ICAM to be directly compared to 1 
cm pathlength HPDA spectra.  
2.3 Results and Discussion 
  
The standard spectrum of metmyoglobin (fig. 2.5) was scaled to the measured 
absorbances of the metmyoglobin in the ICAM-milk and the ICAM+milk (fig. 2.6 and 
2.8) and compared (fig. 2.7 and 2.9).  Both of the curves were well-fitted by exponential 
complements.  These yielded the following transfer functions: 
(4) 𝑦 = 1.423 ∗ (1 − 𝑒−9.937∗𝑥) 
(5) 𝑦 = 0.9375 ∗ (1 − 𝑒−40.03∗𝑥)  
for the ICAM-milk and the ICAM+milk, respectively, where x represents the absorbance 
per centimeter pathlength, and y represents the measured absorbance in the ICAM.  The 
curve for the ICAM+milk showed much greater sensitivity for low absorbances as 
compared to the ICAM-milk (fig 2.10).  In both systems, Lambertian reflection occurs at 
the walls of the ICAM, but the fat globules in the ICAM+milk gave much longer 
pathlength for photon absorption. which explains the higher resolution at lower 
concentrations.   
 The curve fit equations 4 and 5 represent operational equations of input-output. 
The input, x, for equations 4 and 5 represents the typical absorbance per centimeter 
pathlength, and the output represents the measured absorbance in the ICAM.  Reversing 
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equation 3 gives equation 6, which uses the measured absorbance in the ICAM as the 
input, and the output is the typical absorbance per centimeter pathlength.   This will yield 
a typical absorbance per cm from the highly non-linear ICAM measurements. 
(6) 𝑥 = −
ln(
−𝑦
𝐴
+1)
𝐵
  
where x represents the measured absorbance in the ICAM, and A and B represent the 
same parameters from equations 3, 4, and 5.  The inversed transfer functions for the 
ICAM-milk and the ICAM+milk are respectively: 
(7) 𝑥 = −
ln(
−𝑦
1.423
+1)
9.937
  
(8) 𝑥 = −
ln(
−𝑦
0.9375
+1)
40.03
  
where x represents the measured absorbance in the ICAM, and y represents typical 
absorbance per centimeter.   
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Figure 2.5: Standard Spectrum of 22 µM Metmyoglobin 
The standard spectrum of metmyoglobin in a HPDA 8452 spectrophotometer was 
obtained by taking 10 scans (Δλ=2 nm) smoothed using a 9-window quadratic Savitsky-
Golay filter, then averaged.     
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Figure 2.6: Measured Absorbances of Metmyoglobin in the ICAM-Milk. 
A series of increasing concentrations of metmyoglobin in the ICAM-milk had 10 spectral 
scans for each concentration smoothed using a 9-window Savitsky-Golay filter, then 
averaged.  The dilutions were from 31 nM, 110 nM, 270 nM, 620 nM, 1300 nM, 2400 
nM, 3800 nM, 5500 nM, 9000 nM, and 16000 nM, metmyoglobin.  Shown here are the 
curves from 5500-16000 nM are shown. 
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Figure 2.7: ICAM-Milk Transfer Function 
For any particular wavelength, the measured absorbances from the ICAM were plotted on 
the y-axis, whereas absorbance cm-1 data were plotted on the x-axis (see fig. 2.5 and 2.6).  
The 756 data points plotted on this curve for metmyoglobin ranged from 500 to 650 nm. 
The data were well-fitted by an exponential complement 𝑓(𝑥) = 𝐴 ∗ (1 − 𝑒−𝐵∗𝑥),  where 
A equals 1.423 ± 0.036, and B equals 9.937 ± 0.376.  σfit = 0.02775 
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Figure 2.8: Measured Absorbances of Metmyoglobin in the ICAM+Milk 
A series of increasing concentrations of metmyoglobin in the ICAM+milk had 10 spectral 
scans for each concentration smoothed using a 9-window Savitsky-Golay filter, then 
averaged.  The dilutions were 29 nM, 88 nM, 220 nM, 510 nM, 1100 nM, 1900 nM, 3100 
nM, and 4600 nM, metmyoglobin.  
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Figure 2.9: ICAM+Milk Transfer Function 
For any particular wavelength, the measured absorbances from the ICAM were plotted on 
the y-axis, whereas absorbance cm-1 data were plotted on the x-axis (see fig. 2.7 and 2.8).  
The 600 data points plotted on this curve for metmyoglobin ranged from 500 to 650 nm. 
The data were well-fitted by an exponential complement 𝑓(𝑥) = 𝐴 ∗ (1 − 𝑒−𝐵∗𝑥),  where 
A equals 0.9375 ± 0.006917, and B equals 40.03 ± 0.4584.  σfit = 0.01193 
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Figure 2.10: ICAM Transfer Function Comparisons 
Shown are the two transfer functions from figures 2.7 and 2.9. 
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Chapter 3 Validation of the ICAM Transfer Functions 
3.1 Introduction 
Metmyoglobin (Mb+) was used to establish the transfer functions that related non-
linear measured absorbances from the ICAM to the absorbance per centimeter of the Mb+ 
solution within the ICAM.  The ICAM+milk transfer function is appropriate for both 
turbid and non-turbid samples in the presence of the turbid milk.  As a control, the 
spectrum of hemoglobin within the erythrocyte was determined independently of the 
ICAM using thin-layers of packed non-scattering erythrocytes (fig 3.4) in the HPDA 
8452 spectrophotometer.  This technique was used by Professor Parkhurst for crystals of 
erythrocytes containing carbon monoxide in 1967.43  The measured absorbance of 
hemoglobin within the erythrocyte in the ICAM+milk was transformed into absorbance 
per centimeter using the inverse transfer function (fig 3.5 & 3.6).  The absorbances per 
centimeter of the suspension of erythrocytes in the ICAM+milk were compared to the 
absorbances of thin-layer of packed erythrocytes (fig. 3.7).   This comparison showed that 
the transfer function correctly provides the spectrum of the oxyhemoglobin within the 
erythrocyte for erythrocytes in suspension in the ICAM+milk. 
The ICAM-milk transfer function was meant for non-scattering samples.  The 
measured absorbances of hemoglobin in solution in the ICAM-milk were transformed to 
absorbance per centimeter using the inverse transfer function (fig. 3.1 & 3.2).  The 
absorbances per centimeter of hemoglobin in solution in the ICAM were compared to 
absorbances of hemoglobin in solution in the HPDA 8452 spectrophotometer (fig. 3.3).  
This validates the procedure. 
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3.2 Materials and Methods 
Erythrocytes from Professor Parkhurst were collected into citrate tubes at the 
UNL Health Center and on the same day were centrifuged at 1000xg for 3 minutes and 
the supernatant replaced with 1% (w/v) sodium chloride in 50mM phosphate buffer, pH 
6.8.  Continued centrifugation and washing occurred until the supernatant was clear.   
Hemoglobin from such samples was prepared by lysing the cells with a three times 
excess of deionized H2O, centrifuging the sample at 1000xg, and collecting the 
supernatant.  Spectrophotometric studies of hemoglobin were at concentrations above 
150 µM in heme to avoid dissociation of the tetramer.44,45  Long-term storage at 4ºC and 
at -80ºC are discussed in appendix D.  The suspensions of erythrocytes were centrifuged 
at 2000xg for 20 minutes, and the supernatant removed.  The erythrocytes (50 µL) were 
placed on a microscope slide using a modified glass pipette with a larger diameter at its 
tip.  A cover slip was gently placed on the packed erythrocytes.  Using mild pressure and 
rubbing the cover slip resulted in the packed erythrocytes forming a non-scattering 
erythrocyte layer between 20 µm-30 µm in thickness.  The thin packed erythrocyte layer 
was placed in the incident beam of the HPDA 8452, and the spectrum of hemoglobin 
within the erythrocyte taken.  The ICAM+milk was blanked with 270 mL of 1% (w/v) 
NaCl 50mM phosphate pH 6.8 buffer with 2.7 mL of 1% milk.  Afterwards, 600 µL of an 
erythrocyte suspension at 10% hematocrit was added to the ICAM and the spectrum was 
taken.  The ICAM+milk measured absorbance was inverted to absorbance per centimeter 
using the inverse transfer function.  The spectrum of hemoglobin within the erythrocyte 
in the thin layer and the spectrum of the ICAM+milk absorbance per centimeter were 
normalized to 576 nm and compared.   
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3.3 Results and Discussion 
The transfer function approach used metmyoglobin for convenience.  The 
spectrum of oxyhemoglobin, the sample that did not scatter light, was measured using the 
HPDA 8452.  The measurement of oxyhemoglobin in the ICAM-milk, after inverse 
transformation (eq. 7) showed no differences between the two spectra.  The ICAM+milk 
measured absorbance spectrum of hemoglobin within the erythrocyte were similarly 
transformed to equivalent absorbance per centimeter (eq. 8) and compared to the thin-
layer spectrum.  There were insignificant differences between the two spectra.  
Comparison of the spectra of the oxyhemoglobin within the erythrocyte to that of 
hemoglobin in solution showed differences (fig. 3.8 and 3.9).  The spectrum of 
deoxygenated erythrocytes was compared to the literature values for deoxyhemoglobin, 
and a difference appears (fig. 3.10).46  This is the first data showing the spectra of 
oxyhemoglobin and deoxyhemoglobin within the erythrocyte.  
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Figure 3.1: Measured Absorbance of Hemoglobin in Solution in ICAM-Milk 
The measured absorbances of the hemoglobin in solution from the ICAM-milk were 
transformed to standard 1 cm pathlength absorbances using the inverse of the ICAM-milk 
transfer function, 𝑥 = −
ln(
−𝑦
1.423
+1)
9.937
 (eq. 7). 
 
  
31 
 
5 0 0 5 2 5 5 5 0 5 7 5 6 0 0
0 .0 0
0 .0 2
0 .0 4
0 .0 6
 I C A M -M ilk  M e a s u r e d  A b s o r b a n c e s  o f  H e m o g lo b in  in  S o lu t io n
 T r a n s fo r m e d  to  E q u iv a le n t  A b s o r b a n c e  c m
- 1
W a v e le n g th  (n m )
E
q
u
iv
a
le
n
t 
A
b
s
o
r
b
a
n
c
e
 c
m
-
1
 
Figure 3.2: Absorbances of Hemoglobin in Solution in the ICAM-Milk Transformed 
to Equivalent Absorbance cm-1 
The measured absorbances (fig. 3.1) of the hemoglobin in solution from the ICAM-milk 
were transformed to standard 1 cm pathlength absorbances using the inverse of the 
ICAM-milk transfer function, 𝒙 = −
𝐥𝐧(
−𝒚
𝟏.𝟒𝟐𝟑
+𝟏)
𝟗.𝟗𝟑𝟕
 (eq. 7), where y represents the 
measured absorbance and x represents the equivalent absorbance cm-1. 
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Figure 3.3: Comparison of Oxyhemoglobin in Solution using HPDA 8452 and 
ICAM-Milk 
The spectrum from figure 3.2 was scaled and compared to the spectrum of hemoglobin in 
a one centimeter cuvette in the HPDA 8452.  This shows that the ICAM-milk transfer 
function will allow us to transfer measured ICAM absorbances to true equivalent 
absorbance cm-1. 
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Figure 3.4: Thin-Layer Erythrocyte Spectrum in the HPDA 8452 
Packed erythrocytes with the scattering-effects eliminated were placed in the incident 
beam of the HPDA 8452, and the spectrum was taken.  No scattering effects were 
observed since there were no refractive index differences through the illuminated area of 
the sample. 
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Figure 3.5: Measured Absorbances of Oxyhemoglobin within the Erythrocyte using 
ICAM+Milk 
The measured absorbances of the hemoglobin in solution from the ICAM+milk were 
transformed to standard 1 cm pathlength absorbances using the inverse of the 
ICAM+milk transfer function, 𝒙 = −
𝐥𝐧(
−𝒚
𝟎.𝟗𝟑𝟕𝟓
+𝟏)
𝟒𝟎.𝟎𝟑
 (eq. 8), where y represents the 
measured absorbance and x represent the equivalent absorbance cm-1. 
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Figure 3.6: ICAM+Milk Measured Absorbances of Oxyhemoglobin within the 
Erythrocyte Transformed to Equivalent Absorbance cm-1 
The measured absorbances of the hemoglobin in solution from the ICAM+milk were 
transformed to standard 1 cm pathlength absorbances using the inverse of the 
ICAM+milk transfer function, 𝒙 = −
𝐥𝐧(
−𝒚
𝟎.𝟗𝟑𝟕𝟓
+𝟏)
𝟒𝟎.𝟎𝟑
 (eq. 8), where y represents the 
measured absorbance and x represent the equivalent absorbance cm-1. 
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Figure 3.7: Spectra of Hemoglobin within the Erythrocyte in Thin-Layer vs. 
ICAM+Milk 
The absorbance cm-1 obtained of hemoglobin within the erythrocyte using ICAM+milk 
and in the thin-layer were scaled and compared.  This shows that the inverse transfer 
function will transform correctly measured absorbances of turbid samples to equivalent 
absorbance cm-1, correctly eliminating scattering artifacts. 
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Figure 3.8: Comparison of Hemoglobin within the Erythrocyte in Thin-Layer vs. 
Hemoglobin in Solution in HPDA 8452 
Optical differences between oxyhemoglobin within the erythrocyte versus 
oxyhemoglobin in solution are shown here, independent of the ICAM measurements. 
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Figure 3.9: Comparison of Spectra of Oxyhemoglobin in Solution versus 
Oxyhemoglobin within the Erythrocyte Using ICAM 
The optical differences between oxyhemoglobin within the erythrocyte measured with the 
ICAM+milk and oxyhemoglobin in solution are within error the same via figure 3.8 
using the thin-layer method. 
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Figure 3.10: Spectral Differences between Deoxygenated Hemoglobin in Solution 
and within the Erythrocyte 
Deoxygenated hemoglobin in erythrocytes (ICAM+milk) were compared to literature 
values by normalizing both to 590 nm.46   
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Chapter 4 Oxygen Binding in Intracellular Hemoglobin 
4.1 Introduction 
The previous chapter discussed spectral differences between hemoglobin within 
erythrocytes and hemoglobin in solution in both in the oxy- and deoxy- forms.  This 
chapter will discuss preliminary oxygen binding data for erythrocytes using ICAM 
spectrophotometry.  The oxygen binding curve will be used to determine the Adair 
constants and compared to data at the same wavelength for hemoglobin in solution.19  
The binding constants for oxygen to hemoglobin were obtained from the fractional 
saturation of hemoglobin as a function of the concentration of oxygen.  The fractional 
saturation of hemoglobin, ?̅?, is the number of bound oxygen ligands, divided by four.  
The fractional saturation will be compared to the oxygen concentration. 
(9) ?̅? =
[𝑏𝑜𝑢𝑛𝑑 𝑠𝑖𝑡𝑒𝑠]
[𝑏𝑜𝑢𝑛𝑑 𝑠𝑖𝑡𝑒𝑠]+[𝑢𝑛𝑏𝑜𝑢𝑛𝑑 𝑠𝑖𝑡𝑒𝑠]
  
The ligand binding curve near ?̅? = 0.5 can be presented by means of the Hill plot.47   
(10) log
?̅?
(1−?̅?)
= 𝑛𝐻 ∗ log [𝑥]  
Where [x] represents the concentration of the ligand and 𝑛𝐻 is the Hill number.  The Hill 
number provides a measure of the cooperativity of the multi-ligand binding site protein.  
For 𝑛𝐻 <1, the protein exhibits negative cooperativity; and for 𝑛𝐻 >1, the protein exhibits 
positive cooperativity.  The Hill equation can be used to find the half-saturation of the 
erythrocytes (?̅?), where ?̅? represents the oxygen concentration when half of the oxygen-
binding sites of the hemoglobin are bound with oxygen.  In 1925, Adair studied oxygen 
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binding to hemoglobin and found that the Hill plot for hemoglobin was not linear over 
the entire concentration range of oxygen.  He found that four binding constants described 
the oxygenation of hemoglobin.11 Adair used the four binding constants as 
phenomenological macroscopic constants, independent of any detailed model, provided 
the hemoglobin tetramer does not dissociate. 
(1)                    ?̅? =
1
4
∗
𝐾𝐼[𝑥]+2𝐾1𝐾2[𝑥]
2+3𝐾1𝐾2𝐾3[𝑥]
3+4𝐾1𝐾2𝐾3𝐾4[𝑥]
4
1+𝐾1[𝑥]+𝐾1𝐾2[𝑥]2+𝐾1𝐾2𝐾3[𝑥]3+𝐾1𝐾2𝐾3𝐾4[𝑥]4
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4.2 Materials and Methods 
The ICAM+milk was used to measure the deoxygenation of hemoglobin within 
the erythrocytes.  The ICAM needs to maintain a stable temperature, have a way to 
measure the temperature of the solution inside of the ICAM, have a system to measure 
the oxygen concentration, and a system to deoxygenate the sample (fig. 4.1).  The 
temperature of the solution was monitored through a thermistor held in place by the 
rubber stopper (fig. 2.4).  The thermistor was attached to a multimeter.  The thermistor 
was calibrated with a calibration curve of voltage vs. temperature from 15ºC to 40ºC.  
The solution temperature in the ICAM was equilibrated in lab air.  The solution 
temperature in the ICAM was checked over the course of one hour, with a range from 22 
± 0.1 ºC.  The oxygen concentration was monitored using a Yellow Springs Instruments 
5300 oxygen electrode (appendix C).   The correct air pressure in the lab was 698 mmHg 
(appendix E). Both the temperature and the correct air pressure in the lab were used to 
determine the oxygen concentration in 100% air-equilibrated solution, which was 250 
µM.  
The deoxygenation of the sample employed ascorbic acid in combination with L-
ascorbate oxidase from Cucurbita sp. obtained from Sigma-Aldrich.  One unit of the 
ascorbate oxidase oxidized one µmole of L-ascorbate to dehydroascorbate per minute at 
pH 5.6 at 25ºC.  The ascorbate oxidase from Sigma had 0.250 milligrams of ascorbate 
oxidase per unit. The oxidation of ascorbic acid to dehydroascorbate occurs in a four-
electron reduction of oxygen to water without the production of free radicals.  The 
ascorbate oxidase contains three moles of copper.  The two copper centers in ascorbate 
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oxidase store reducing equivalents of from the ascorbate oxidase.  This is confirmed by 
EPR signals consistent with the presence of free-radicals.  The two copper centers are 
known to consist of a single type I copper site and a trinuclear copper, in which three 
coppers are separated by 12 Å to 15 Å from the single type I copper site.48  It was found 
that the two copper sites interact separately with the two substrates, and that the free-
radicals were contained within the enzyme and do not produce hydrogen peroxide.49 This 
removed the possibility of free-radicals forming during the deoxygenation of the 
erythrocytes from enzymatic action. 
 
The ICAM+milk had a total volume of 272 mL, consisting of 260 mL of 1% 
(w/v) sodium chloride, 50 mM phosphate buffer, pH 6.8 with the addition of 10 mL of 
2.6 M ascorbic acid, and 2.76 mL of 1% milk.  A syringe of 25 U of ascorbic acid was 
prepared in 1 mL 1% (w/v) NaCl, 50 mM phosphate buffer, pH 6.8.  The tubing leading 
into the ICAM had a valve for enzyme delivery (fig. 2.4).  A second empty syringe was 
also placed in the ICAM to capture overflow (appendix B).  The dead time of enzyme 
mixing was measured to one second.  At time zero, the enzyme was injected, and the 
valve promptly closed.  The ICAM milk system scanned every nanometer from 600 to 
500 nanometers with a signal averaging of 66 milliseconds.  The spectral bandwidth was 
set to 0.6 nanometers to ensure adequate signal-to-noise ratios.  The monochromator 
scanned from 600 to 500 nanometers in 12 seconds, then slewed back to 600 nanometers 
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in 3 seconds.  During the slew time, no data was recorded.  A reading at the same 
wavelength occurred every 15 seconds. The oxygen depletion was measured using the 
oxygen electrode.  After 8 minutes of unchanged absorbance readings, 1 mL of 0.57 M 
sodium dithionite was injected to ensure complete deoxygenation.   
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Figure 4.1: Block Diagram of the Instrumentation 
The ICAM system employed a Cary 300 to measure spectra from light-scattering sources.  
The temperature is monitored by a thermistor inside the ICAM and the signal is 
monitored by a multimeter.  The O2 concentration is monitored by a Yellow Springs 
Instruments 5300 oxygen electrode (appendix C).  Circulating water from a water bath 
can be used to set the temperature. 
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4.3 Results and Discussion 
Preliminary workup of the oxygen binding data for erythrocytes used 576 nm 
absorbances.  The gradual loss of absorbance at 576 nm both from the measured ICAM 
absorbance and the equivalent absorbance cm-1 is depicted in figures 4.3 and 4.4.  The 
voltage of the oxygen electrode (fig 4.2) was set to 5 V with air-equilibrated water, 
corresponding to air-equilibrated water at a concentration of 250 µM O2 (appendix E). 
The voltage vs. time was fit to a curve fit of: 
(11) 𝑉𝑜𝑙𝑡𝑎𝑔𝑒 = (1.781 ∗ 10−12𝑥4) − (9.79 ∗ 10−9𝑥3) + (1.933 ∗
10−5𝑥2) − (0.01634𝑥) + 5.096   
(12) [𝑂2] =
𝑉𝑜𝑙𝑡𝑎𝑔𝑒
5
∗ [𝑂2] 𝑖𝑛 𝑎𝑖𝑟 − 𝑒𝑞𝑢𝑖𝑙𝑖𝑏𝑟𝑎𝑡𝑒𝑑 𝑤𝑎𝑡𝑒𝑟 
where x represents the time in seconds.  The voltage divided by 5 and multiplied by the 
[O2] of air-equilibrated water obtains the concentration of oxygen dissolved in the sample 
at a given point in time.  The first absorbance at 576 nm started at 0 seconds and repeated 
every 14.8 seconds over the course of 1600 seconds. 
The Adair constants K1-K4 were determined using Gill’s ingenious equations.50  
First, the absorbance changes at 576 nm in the ICAM+milk were used to determine the 
franctional saturation of hemoglobin within the erythrocyte using the earlier equation:  
(13) ?̅? = [𝐴𝑏𝑠𝑥 − 𝐴𝑏𝑠0]/[𝐴𝑏𝑠∞ − 𝐴𝑏𝑠0]  
where ?̅? represents the fractional saturation of the hemoglobin within the erythrocyte, 
Absx represents the equivalent absorbance per centimeter of the hemoglobin within the 
erythrocyte at a given point in time, Abs0 is the equivalent absorbance per centimeter of 
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fully deoxygenated hemoglobin within the erythrocyte, and Abs∞ is the equivalent 
absorbance per centimeter of fully oxygenated hemoglobin within the erythrocyte.  The 
measured absorbance in the ICAM+milk follow a non-linear relationship with respect to 
concentration.  Due to this, the measured absorbances at 576 nm in the ICAM+milk were 
transformed to equivalent absorbance per centimeter using the reversed transfer function 
(eq. 8): 
(8)      𝑥 = −
ln(
−𝑦
0.9375
+1)
40.03
  
where y is the measured absorbance in the ICAM, and x is the equivalent absorbance per 
centimeter.  In this manner, the measured absorbances at 576 nm ranging from 0.453 to 
0.329 were transformed to equivalent absorbance per centimeter ranging from 0.0165 to 
0.0108.  The equivalent absorbance at 576 nm for deoxygenated hemoglobin within the 
erythrocyte, or Abs0, was determined experimentally with the addition of dithionite at 
very low concentrations of oxygen.  The equivalent absorbance at 576 nm for fully 
oxygenated hemoglobin within the erythrocyte, or Abs∞, was found by extrapolation.  In 
order to determine Abs∞, a double-reciprocal plot was used plotting the inverse of F (eqs. 
14-16) against the inverse of oxygen concentration, 1/[x], using the data points for the top 
10% of absorbances (fig. 4.6).    When a linear fit of the double-reciprocal plot is 
compared to equation 16, the y-intercept is A from equation 15.  When A is added to the 
known Abs0, Abs∞ is obtained.  When Absx, Abs0, and Abs∞ are used with equation 2, the 
fractional saturation of hemoglobin with the erythrocyte can be determined.  The slope of 
48 
 
the double-reciprocal plot can be used to determine S2 of Gill, the upper limiting slope, 
which can be used in equation 17 to determine K4. 
(14) 𝐹 = 𝐴𝑏𝑠𝑥 − 𝐴𝑏𝑠0  
(15) 𝐴 = 𝐴𝑏𝑠∞ − 𝐴𝑏𝑠0  
(16) 
1
𝐹
=
1
𝐴
+
1
𝐴𝑆2
∗
1
𝑥
  
(17) 𝑆2 = 1/[4 ∗ 𝐾4]  
 With the fractional saturation obtained for any value of Absx, the plot of the 
fractional saturation versus oxygen concentration using data from the bottom 25% of the 
fractional saturation curvecan be used to determine the first two Adair constants, K1 and 
K2.  The fractional saturation was plotted against oxygen concentration and fitted with a 
quadratic equation with the y-intercept at 0 (fig. 4.7).  The fit can be used to determine the 
Gill parameters S1 and C1 from equation 18,  
(18) 
[𝐴𝑏𝑠𝑥−𝐴𝑏𝑠0]
[𝐴𝑏𝑠∞−𝐴𝑏𝑠0]
= 𝑆1𝑥 ∗ 𝐶1𝑥
2 
where S1 is a limiting slope and C1 is the curvature at the bottom of the oxygen binding 
curve.  The Adair constants K1 and K2 can be found directly from S1 and C1 using 
equations 19 and 20. 
(19) 𝑆1 = 𝐾1/4 
(20) 𝐶1 = [2𝐾1𝐾2 − 𝐾1
2]/4  
The next two parameters, the Hill number, 𝑛𝐻  and the concentration of oxygen at half-
saturation, or ?̅?, were determined using the Hill plot (fig. 4.5).  The Adair constant K3 was 
determined through a univariate fit of equation 1 using Graphpad (fig. 4.8).  Figure 4.8 
shows the Adair constant curve fit versus experimental data. 
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 Hemoglobin within Erythrocytes 
Abs0 0.0107 
Abs∞ 0.0167 ± 0.00013 
K4 2.7306 ± 0.3684 
K1 0.0353 ± 0.00638 
K2 0.0878 ± 0.0144623 
?̅? 23.28 ± 4.6µM 
𝑛𝐻  2.036 ± 0.1155 
K3 0.000448 ± 0.0000378 
 
Table 3.1: Parameters for Oxygen Binding to Hemoglobin within the Erythrocyte 
Determined at 576 nm 
Adair constants with the two parameters used for the oxygen binding curve fit are 
compared to literature values. 
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 The preliminary data show weaker oxygen binding of oxygen-to-hemoglobin 
within the erythrocyte at lower oxygen concentrations when compared to hemoglobin in 
solution.  This corresponds to more efficient delivery of oxygen to tissues under high 
oxygen demand.  Our data also show the oxygen binding at higher oxygen concentration 
is tighter than hemoglobin in solution, for a more efficient uptake of oxygen for the 
erythrocytes in the lungs.  During the spectrophotometry studies of hemoglobin, the heme 
concentration was kept above 150 µM to ensure the α2β2 tetramer does not dissociate to  
αβ dimers.45  The intracellular hemoglobin concentration inside human erythrocytes is 20 
mM, and the concentration within the crystal is 40 mM.  The R/T conformational change 
cannot be accommodated within the same crystal lattice.  Inter-tetramer distances within 
the erythrocyte are only 25% longer than in the crystal, perhaps the minimum needed for 
the R/T conformational change.  There are clear functional differences in the hemoglobin 
tetramer within the erythrocyte versus in solution that correlate with the difference in 
packing. 
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Figure 4.2: Oxygen Electrode Measurements 
The function  𝒇(𝒙) = 𝑨𝒙𝟒 + 𝑩𝒙𝟑 + 𝑪𝒙𝟐 + 𝑫𝒙 + 𝑬  was used to fit the 1529 data points 
of voltage over time during the deoxygenation of erythrocytes. The curve fit uses A = 
1.781 * 10-12; B = -9.79 * 10-9; C =1.933 * 10-5; and D=  -0.01634; and E equals 5.096, 
with σfit = 0.0117. 
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Figure 4.3: Measured ICAM Absorbances during Continuous Deoxygenation of 
Erythrocytes within ICAM+Milk 
Every 5th scan for the ICAM is shown for clarity.  The measured ICAM absorbances 
were transferred to equivalent absorbance cm-1 using the reversed transfer function (eq. 8) 
for ICAM+milk (fig. 4.4). 
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Figure 4.4: Equivalent Absorbances during Continuous Deoxygenation of 
Erythrocytes within the ICAM+Milk 
Every 20th scan for the ICAM is shown for clarity.  The measured absorbances (fig. 4.3) 
were transformed with equation 8 to calculate the equivalent absorbance cm-1 at 576 nm.   
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Figure 4.5: Hill Plot of Oxygen Binding to Hemoglobin within the Erthryocyte 
The Hill equation was fitted to the data at half-saturation from ?̅? at 0.821 to 0.218 with a 
linear fit 𝑓(𝑥) = 𝑚𝑥 + 𝑏, where x is the log of oxygen concentration, m equals 2.071 ± 
0.1155, and b equals -2.831 ± 0.1632.  The Hill coefficient, nH was 2.071 ± 0.1155 by 
least-square, and the half-saturation ?̅? was 23.2 ± 4.6 µM.  σfit = 0.0761 
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Figure 4.6: Fitting the Top 10% Portion of the Oxygen Binding Curve 
The top 27 fractional saturation data points were used to find both Abs∞ and S2 by a 
double reciprocal plot of 1/F vs. 1/x, where 𝑭 = 𝑨𝒃𝒔𝒙 − 𝑨𝒃𝒔𝟎 and x is the oxygen 
concentration in µM.  A linear fit with 
𝟏
𝑭
=
𝟏
𝑨
+
𝟏
𝑨𝑺𝟐
∗
𝟏
𝑿
 gives the values of Abs∞ and S2 
using equations 13-15.  The linear fit of 𝒇(𝒙) = 𝒎𝒙 + 𝒃 gave m = 1845 ± 249.2, and b = 
168.7 ± 3.703.  Calculations using equations 14-17 gave Abs∞ = 0.0167 ± 0.00013.  The 
Gill parameter S2 could be determined using the linear fit, and equation 17 with S2 
determined K4 = 2.7306 ± 0.3684.  σfit = 7.909 
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Figure 4.7: Fitting the Low Portion of the Oxygen Binding Curve 
Determining S1 and C1 from the curve fit 𝒇(𝒙) = 𝑺𝟏𝒙 + 𝑪𝟏𝒙
𝟐. S1 was equal to 0.008818 ± 
0.01601, while C1 was equal to 0.001238 ± 0.0002044.  Using the Gill equations, these 
can be used to calculate K1 and K2. σfit = 0.02202 
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Figure 4.8: K3 Determination through Univariate Fitting 
This figure shows the calculated oxygen binding curve using the Adair constants with 
univariate fitting to determine K3 = 0.000448 ± 0.0000378, with σfit = 0.04933. 
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Figure 4.9: Oxygen Binding of Human Hemoglobin in Solution vs. within the 
Erythrocyte 
The oxygen binding curve of human hemoglobin within the erythrocyte was determined 
at pH 6.8 and 22ºC, and compared to literature values.    
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Chapter 5 Future Directions and Conclusions 
Marked functional differences between the hemoglobin in solution and the 
hemoglobin within the erythrocyte have been shown and quantified.  It is now important 
to determine the binding free energies and enthalpies at the normal body temperature of 
37ºC.  Continued studies of adult human hemoglobin ranging over pH and temperature 
should also be done with Parkhurst’s multiple wavelength global analysis.  This will give 
the complete thermodynamic description of oxygen binding in normal human 
hemoglobin within the erythrocyte. 
Thermodynamic studies of disease state erythrocytes, such as sickle-cell anemia 
(HbS), are expected to give new insight into the disease states of hemoglobin.  HbS 
hemoglobin showed high cooperativity with unusually large concentration-dependent Hill 
coefficients.51  However, this conclusion has been questioned.52  The thermodynamics of 
oxygen binding with hemoglobin S are highly concentration dependent.   The 
spectrophotometry of hemoglobin S required polymers and linkage theory to ensure the 
dimerization of hemoglobin does not occur in solution while the hemoglobin S is in close 
interaction with other tetramers.  Studies of HbS within the erythrocyte would give clarity 
of the concentration-dependent thermodynamics of sickle-cell anemia.   
 Different iterations of the ICAM could also be explored.  Parkhurst’s derivations 
of the ICAM-milk showed the curve fit to be an exponential complement, which were 
shown in chapter 1.  The derivations for a cube have also been deduced, and for a cuvette 
with reflective walls designed by 3D printing.   
60 
 
 
 
Appendix A Apparatus Holder Design 
A.I Introduction 
Early in the studies with the ICAM roundbottom flask, the ICAM was housed in a 
very simple apparatus in the sample chamber.  That apparatus showed noticeable 
absorbance changes over time due to a shift of the ICAM during operation.  Due to these 
flaws, a new apparatus was designed to eliminate absorbance drift.    
A.II Materials and Methods 
The initial design of the ICAM system utilized a 250 mL roundbottom flask 
coated on its outer surface with a flat white paint.  A pneumatically driven magnetic stir 
plate was set into the instrument sample chamber with a cork roundbottom flask holder to 
hold the ICAM when in operation.  The incident light traveled through the ICAM and 
was scattered, while the reference beam in the Cary 300 was kept in the same logarithmic 
range as the incidence beam by use of a neutral density filter. 
To determine the instrument noise with this setup, the ICAM was zeroed and 
blanked with 270 mL 50 mM phosphate buffer, pH 6.8, with the baffle in place. 
Afterwards, 1000 µL of 1 mM hemoglobin solution was added to the ICAM, and 1000 
scans were run over the course of 150 minutes.  Figure A.1 shows 10 spectra, each 
representative of 100 scans smoothed by a 9 point quadratic Savitzky-Golay filter, and 
averaged together.  Unfortunately, there was a loss of absorbance due to movement of the 
ICAM in the initial apparatus.  It was decided a new ICAM apparatus holder needed to be 
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designed.  The new apparatus holder was designed out of aluminum using kinematic 
design principles.53  The new design was tested to determine if the absorbance reading at 
576 nm was stable over the course of 1000 scans using 270 mL 50 mM phosphate buffer, 
pH 6.8 with 1000 µL 652 mM human hemoglobin, and the ICAM did not move during 
operation.   
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A.III Results and Discussion 
 The measured absorbances in the ICAM-milk before the new apparatus holder 
was built showed a steady decrease in absorbance over the course of the 150 minutes due 
to ICAM slippage (fig. A.1).  The instrument was unstable, constantly shifting on top of 
the cork holder. When the new ICAM apparatus holder was introduced, there was no 
change in absorbance over the course of the 150 minutes (fig. A.2).   
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Figure A.1: Measured Absorbance in ICAM-Milk Due to ICAM Slippage in the 
Initial Version of the ICAM 
A loss of absorbance at 576 nm was noticed when 1000 scans of hemoglobin were each 9 
point quadratic Savitzky-Golay filtered, then averaged into groups of 100.  This steady 
loss was due to the progressive movement of the ICAM. 
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Figure A.2: Stability of the New ICAM Holder 
The ICAM was placed in the new holder and its change of absorbance over time was test 
using 270 mL 50 mM phosphate buffer, pH 6.8 with 1 mL of 652 mM hemoglobin.  This 
showed no change over time. 
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Appendix B Settings of the ICAM  
During the final experiments, the standard procedure was to run the experiment 
from 600 nm to 500 nm unless otherwise stated.  The stepper motor in the Cary 300 
stepped every 1 nm (λ).  The minimum time for an absorbance measurement was set by 
the speed of the double choppers.  The time for an absorbance measurement at each 
wavelength was set to 66 milliseconds.  The Cary 300 stepper motor would scan from 
600 nm to 500 nm (unless otherwise stated) in the course of 12 seconds.  The stepper 
motor would slew from 500 nm back to 600 nm with no absorbance measurements taken 
during this time.  The slewing took 2.8 seconds.  The timings of the stepper motor were 
determined through direct observation from numerous consecutive runs. 
The stirring speed was controlled by the pressure of the air flowing through the 
pneumatically driven magnetic stir plate.  The highest pressure allowed without any 
wobbling was 18 PSI.  In order to ensure consistent stir speeds, the revolutions per 
second in the ICAM were determined by holding a stethoscope to the neck of the ICAM 
and attaching the earpiece to a microphone recording the sound.  A freeware Winscope 
program developed by Andy Collinson sampled input waveforms from a computer’s 
microphone measurements.54  The sample was stirred by a Teflon coated magnet at a 
constant speed of 2.7 revolutions per second to ensure a homogenous solution within the 
ICAM during its operation (fig. B.1).  The stirring dead time was determined by adding a 
sample of metmyoglobin into the ICAM+milk via a syringe.  The metmyoglobin 
spectrum was constant within 1.1 seconds (fig. B.2).   Due to the short dead time, no 
corrections for the stirring dead time were necessary. 
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Figure B.1: Oscilloscope Microphone Measurements at 18 PSI 
Each grouping represents a half-turn of the stir bar in the ICAM at 18 PSI.   The distance 
between one set of peaks and the other was determined to be 0.185 seconds per half-turn, 
or 2.7 revolutions per second.   
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Figure B.2: Stirring Dead Time of ICAM+Milk 
The stirring dead time was determined by using a solution of 462 µM metmyoglobin in 
50 mM sodium phosphate, pH 8.0.  The ICAM was blanked with 268.2 mL 50 mM 
sodium phosphate, pH 8.0 with 2.7 mL 1% milk.  1.7 mL of the metmyoglobin solution 
was injected into the  ICAM+milk and the absorbance change at 500 nm recorded over 
time. 
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Appendix C Automated Oxygen Electrode  
 
 The oxygen concentration in the ICAM during the deoxygenation process was 
measured through a YSI 5300 oxygen electrode.  The YSI oxygen electrode was a Clark 
electrode, which reduced oxygen and required stirring to maintain equilibrium with the 
electrode environment.  The Clark oxygen electrode uses platinum-silver electrodes 
surrounded by potassium chloride and the electrode chamber separated from the reaction 
chamber by a Teflon membrane.  The Teflon membrane was permeable to dissolved 
oxygen, and the electrodes generated a reaction with the oxygen being the limiting 
reagent.   The reaction is O2 + 4 e
- + H2O  4 OH-.  The instrument was self-calibrating 
with analog measurements shown on the instrument’s interface in terms of percentages.   
The instrument was set to 100% using air-equilibrated water.  The calculation of the 
oxygen concentration for air-equilibrated water is in appendix V.  The analog signal was 
converted to digital in order to ensure fast, precise oxygen concentration measurements.  
The conversion occurred using a Sparkfun Redboard microprocessor.  A wire ran from 
the differential port on the YSI 5300 to the A0 analog port on the Redboard, while another 
wire ran from the grounding port on the YSI 5300 to the grounding port on the Redboard.  
The Redboard was connected to a computer using a mini-USB port on the Redboard to a 
USB port on the computer. The Redboard was programmed using Arduino, a freeware 
program provided by Sparkfun (see fig. C.1). 
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/* 
Analog-to-Digital 
Reads an analog input on pin 0, converts it 
to voltage, and prints the result to the serial 
monitor. 
*/ 
 
// the setup routine runs once when you 
press reset: 
void setup() { 
// initialize serial communication at 9600 
bits per second: 
Serial.begin(9600); 
} 
 
// the loop routine runs over and over 
void loop() { 
// read input on analog pin 0: 
int sensorValue = analogRead(A0); 
// Convert the analog reading (which goes 
from 0 - 1023) to a voltage (0 - 5V): 
float voltage = sensorValue * (5.0 / 1023.0); 
// print out: 
Serial.println(voltage); 
delay(1000); 
} 
 
Figure C.1: Arduino Program for the Oxygen Electrode 
This program was programmed into the Redboard microprocessor.  The microprocessor 
took the analog signal as a scale from 0-1023 bits, and converted it to digital signal as 
voltage (0-5V).  The voltage could be transformed into percent relative oxygen by 
dividing by 5. 
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Appendix D Erythrocyte Storage, Retrieval, and Survival 
D.I Introduction 
Blood transfusion was the most important medical advance of World War I with 
the development of a citrate-glucose solution used to store blood.55  At the time, however, 
it was not clear how to store frozen blood and later recover it.  In the 1950s, Lovelock 
stated that the damage to red blood cells during the freezing and thawing process was due 
to the osmotic stress.56  Shortly after, Smith, working with Polge, discovered glycerol as 
the first practical cryoprotectant molecule, and used it to cryopreserve, thaw, and 
subsequently wash the red blood cells free of cryoprotectants.57,58  It was thought that the 
storage of red blood cells would eliminate the problems associated with erythrocyte 
suspensions in transfusion: seasonal shortages, rare blood types, and natural disasters.  
Two main groups of cryoprotectants have been developed, classified as “penetrating” and 
“non-penetrating.”59,60  The former, such as glycerol, invade the cell and change the 
osmotic equilibrium during freezing.  In this way, the volume reduction due to 
intracellular ice formation is reduced.  The second group of cryoprotectants form a shell 
around the erythrocyte in a process called vitrification, and in this way, protect the red 
blood cells from osmotic damage.  During the freeze-thaw-wash (FTW) processing of red 
blood cells, there are two main problems.  One of them is the initial lysis of red blood 
cells, and the second is the post-thawing survivability of the red blood cells.  If enough 
osmotic damage occurs, or if the cell function is limited after post-FTW, or if the cell 
cannot maintain integrity in the thawing solution, then hemolysis will happen rapidly 
over the course of a few days.  Our goal post-FTW is focused on the latter.   We make the 
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assumption that post-FTW survivability indicates the RBC are more physiologically 
relevant. 
The goal of post-FTW survivability is based upon post 24-hour transfusion 
survival rates.  National Academy of Science NRC has arbitrarily established a survival 
of 70% in 24 hours post-transfusion as the acceptable level for the viability of preserved 
erythrocytes.  For our work, we arbitrarily set our goal as less than 1% per day.  This 
would ensure a sample that would remain relatively stable over the course of 2-3 weeks.  
We found that using 40% (v/v) glycerol as a cryoprotectant and using AS-3 storage 
buffer (100 mL H2O, 1.10g of dextrose monohydrate, 0.558g of sodium citrate dihydrate, 
0.276 g of monobasic sodium phosphate monohydrate, 0.42 g of citric acid monohydrate, 
and 0.030 g of adenine) offered our samples three-weeks of adequate post freeze-thaw-
wash survival at 4ºC.61,62 
D.II Materials and Methods 
Initially, our work began with Flegel’s work at the NIH, who focused on using 
polyvinyl pyrrolidone (PVP) as a non-invasive cryoprotectant (16).   Human blood from 
KH or LJP was collected into concentrated ethylenediaminetetraacetic acid, and stored at 
4ºC.  The samples were centrifuged at 1000xg for 5 minutes to isolate the red blood cells.  
The packed RBC samples had the supernatant removed, and the lost volume replaced 
with 1% w/v NaCl, 50 mM sodium phosphate buffer pH 6.8 (PBS buffer).  This process 
was repeated until the supernatant was clear.  The packed red blood cells were 
cryoprotected in one of two ways: fast-freezing through non-invasive cryoprotectants, 
and slow-freezing through invasive cryoprotectants. 
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With the non-invasive cryoprotectants, one volume of packed erythrocytes was 
introduced into one volume of PVP freezing solution (27mL of 30% w/v bovine serum 
albumin with 23% (v/v PVP in deionized H2O). The mixture was allowed to equilibrate 
for 1 hour.  Afterwards, the mixture was pipetted dropwise into a liquid nitrogen-filled 
Dewar flask.  These droplets were collected with a metal spatula, and placed into a 
cryovial tube with the top punctured several times.  Both the cryovial tubes and the metal 
spatula were chilled with liquid nitrogen beforehand to ensure the droplets didn’t thaw 
and stick on contact.  Afterwards, the cryovial tubes were placed into the -80ºC freezer 
until thawed. 
During the thawing process, the desired amounts of droplets (around 80-160 µL 
each) were placed into 1.5 mL of PBS buffer at 37ºC with gentle shaking.  After 
complete suspension, the sample was washed with storage buffer at 3 fold-excess until no 
hemolysis occurred (around 2-3 washes).  This lowered the PVP left in solution to 
approximately 0.0001 M.  Afterwards, the red blood cells were resuspended, aliquoted 
into individual-use Eppendorf tubes and placed into 4ºC storage until use.  The two 
storage buffers used were 1% PBS buffer and AS-3 solution.  
Valeri’s work with the Naval Blood Research Laboratory focused on invasive 
cryoprotectants.61,62  Two volumes of a glycerol freezing solution (50% w/v glycerol, 1% 
w/v 2-hydroxy-propanoic acid, 1% w/v KCl, 50 mM sodium phosphate buffer, pH 6.8) 
were added for every volume of packed red blood cells.  The mixture was allowed to 
equilibrate for 1 hour.  Afterwards, the mixture was aliquoted into cryovials, and the 
temperature was lowered at 1ºC/min by insulating the test tubes in a room-temperature 
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Styrofoam box, which was placed into the freezer and the temperature checked every 
hour until -80ºC was reached. 
Two different thawing procedures were used to remove the intracellular glycerol.   
The frozen glycerolized samples were warmed to 37ºC.  Afterwards, the samples were 
centrifuged at 1000xg and the supernatant removed.  1 volume of 12% PBS buffer was 
added dropwise to 3 volumes of the thawed RBC sample with gentle mixing, and 
equilibrated at room temperature for 3 minutes.  Afterwards, 3 volumes of 0.2% dextrose 
(w/v), 0.9% saline (w/v) was added dropwise with gentle shaking, then left to equilibrate 
for 3 minutes, and this process was repeated 4 times.  At this point, the sample was 
centrifuged for 3 minutes at 1000xg, and then an eighth of the total volume was aspirated, 
replaced with storage buffer, then the packed RBC were resuspended.  This process was 
repeated 8 times, with the following volumes aspirated and replaced: 1/8th, 1/4th, 3/8th, ½, 
and finally 4/5th.  Afterwards, the RBC samples were aliquoted into one-use Eppendorf 
tubes and placed into the 4ºC refrigerator.  The two storage buffers used were 1% PBS 
buffer and AS-3 solution. 
D.III Results and Discussion 
Hemolysis rates were measured by removing the sample from the 4ºC 
refridgerator and centrifuging the sample for 3 minutes at 1000xg.  The supernatant was 
removed and placed in a pre-tared Eppendorf tube.  The packed erythrocytes were 
resuspended using storage buffer.  Both samples were massed, and the density assumed 
to be 1g/mL.  Both of these solutions had 10-100 µL removed and placed into 2 mL 
deionized H2O.  The absorbances at 578 nm for both of these diluted solutions were 
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measured and their final concentrations measured.   The total heme lysed versus the total 
heme in cells give us the total hemolysis and total survival. 
We assume that higher post-FTW survival indicates the RBC are more likely to 
be physiologically relevant.  Based on our results, we decided that using Valeri’s 
methods with glycerol and AS-3 solutions would be most effective as compared to 
Flegel’s method with polyvinylpyrrolidone.  Personal contact with Flegel and Valeri, 
revealed that their aims were different.  Valeri was focused on survival rates post FTW at 
4ºC due to his career’s work with the US naval research laboratories.  He was focused on 
keeping rare blood types viable on warships for long periods of time.  Flegel, on the other 
hand, focused his work on laboratories using the thawed red blood cells on that given 
day, and focused on quick and efficient methods to thaw erythrocytes for a single day’s 
use.  
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Figure D.1: Lysis of Erythrocytes During 4 Degrees Celsius Storage in AS-3 Post-
Glycerol Freeze-Thaw-Wash 
Valeri’s methods of erythrocyte storage and retrieval using glycerol as a cryoprotectant 
for the erythrocytes at -80ºC followed by AS-3 solution in the erythrocyte suspension at 
4ºC proved adequate for three weeks. 
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Figure D.2: Lysis of Erythrocytes During 4 Degrees Celsius Storage in PBS after 
Post-Polyvinyl Pyrrolidone -80ºC Storage 
Ten days after retrieval from -80ºC storage, 60% of the erythrocytes had lysed in 4ºC 
PBS buffer.    
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Appendix E Dissolved Oxygen Calculations 
In order to determine the concentration of air-equilibrated water, the true air 
pressure and temperature were recorded.  The temperature of the lab was recorded with a 
thermometer.  The air pressure and humidity were given by KLNK airport.  The lab was 
determined to be 75 feet above KLNK airport. The true air pressure was given 
determined by:  
(21)           𝐿𝑎𝑏 𝐴𝑖𝑟 𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 = [𝐾𝐿𝑁𝐾 + (75 𝑓𝑒𝑒𝑡 ∗
26 𝑚𝑚𝐻𝑔
1000 𝑓𝑒𝑒𝑡 𝑎𝑏𝑜𝑣𝑒 𝑠𝑒𝑎 𝑙𝑒𝑣𝑒𝑙
)]  
The oxygen activity can be determined using the gas solubility tables. 
(22)                𝑋𝐴 =
𝛼𝑇(0.20946)
𝑅(273.18)
∗
𝑃𝑏−𝑃𝑇𝐻
760 𝑚𝑚𝐻𝑔/𝐴𝑡𝑚
 
Where: 𝛼𝑇 = the volume of oxygen in liters absorbed by one volume of water when the 
pressure of the gas itself amounts to 760 mm.63 
 R = 0.082054 liter atm. deg.-1 mol-1 
 Pb = ambient lab air pressure in mmHg 
 PT = ambient pressure of water at a temperature read from the table 
 H = ambient %relative humidity divided by 100. 
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